North America Lung Cancer Screening Software Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • Jul 2020
  • North America
  • 350 Pages
  • No of Tables: 154
  • No of Figures: 52

North America Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions, Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking),  Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Third Party Distributor), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027

North America Lung Cancer Screening Software MarketMarket Analysis and Insights : North America Lung Cancer Screening Software Market

Lung cancer screening software market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 19.2% in the forecast period of 2020 to 2027 and is expected to reach USD 48,965.25 thousand by 2027, as increasing prevalence of lung cancer cases in North America and increasing awareness regarding the benefits of early diagnosis and frequent screening are the major drivers which propelled the demand of the lung cancer screening software market in the forecast period.

Lung cancer screening is a process of detection and identification of lung cancer with usage of different technologies and software. Rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. Lung cancer screening software helps in management for patient’s participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate and transfer data to clinicians and patients. Additionally, this software enables to identify patients at risk and automates flow of data with integrated electronic health records. Lung cancer screening program solutions have several advantages, including identifying, registering and monitoring patients, reporting, integrating and analysing data, and communicating with patients, which in turn increases their admission to hospitals and radiology.

Lung cancer screening software has increased as compared to the precise year with increasing prevalence of lung cancer along with increasing number of lung cancer screening. Additionally, the demand of lung cancer screening software increases with growing number of screening programs across the globe and worldwide, lung cancer is the leading cause of cancer and mortality. For instance, the American Lung Association has united women and loved ones all over the region to fight the number one killer of men and women in the United States during lung cancer awareness month in November 2019. Further, technical issues related with the available software, scarcity of technically knowledgeable professionals for cancer diagnosis is expected to restraint the usage of lung cancer screening software and is expected to slow down the growth of the lung cancer screening software market in the forecast period. 

The lung cancer screening software market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the lung cancer screening software market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.  

North America Lung Cancer Screening Software MarketNorth America Lung Cancer Screening Software Market Scope and Market Size

Lung cancer screening software market is segmented on the basis of mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel.

  • On the basis of mode of delivery, the lung cancer screening software market is segmented into cloud based solutions, on-premise solutions, and web based solutions. In 2020, cloud-based solutions segment for lung cancer dominates in the lung cancer screening software market due to the relatively lower need for infrastructure in the region.
  • On the basis of product, the lung cancer screening software market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACs, practice management, and audit log tracking. In 2020, lung cancer screening radiology solution segment holds majority of the share in the lung cancer screening software market due to the supply of high quality products and the increased demand for radiation solution for lung cancer in the region.
  • On the basis of type, the lung cancer screening software market is segmented into computer-assisted screening and traditional screening. In 2020, computer-assisted screening segment holds majority of the share in the lung cancer screening software market due to fewer doctors' demands and rapid results on lung screening in the region.
  • On the basis of application, the lung cancer screening software market is segmented into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In 2020, non-small cell lung cancer (NSCLC) segment holds majority of the share in the lung cancer screening software market due to increasing incidence of non-small cell lung cancer (SCLC) in the region.
  • On the basis of platform, the lung cancer screening software market is segmented into standalone and integrated. In 2020, standalone segment holds majority of the share in the lung cancer screening software market due to focused functionality and maximum accuracy in the region.
  • On the basis of purchase mode, the lung cancer screening software market is segmented into individual and institutional. In 2020, institutional segment is expected to dominate the lung cancer screening software market as hospitals, oncology centers and operating theatres are largely buying and reconsidering their licenses / services, although institutional acquisitions are to seek the benefits of liquidity purchases, discounts and easy product offerings in the region.
  • On the basis of end user, the lung cancer screening software market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others. In 2020, oncology centers segment holds majority of the share in the lung cancer screening software market due to the increasing shift to preventive and diagnostic testing, forcing improvements and technological innovations in the region. 
  • On the basis of distribution channel, the lung cancer screening software market is segmented into direct tenders, and third party distributor. In 2020, direct tenders segment holds majority of the share in the lung cancer screening software market due to the availability of wide range of products that are accessible to patients in the region.

Lung Cancer Screening Software Market Country Level Analysis

The lung cancer screening software market is analysed and market size information is provided by country, mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel as referenced above.

The countries covered in the lung cancer screening software market report are the U.S., Canada, and Mexico.

The U.S. is dominating in the North America lung cancer screening software market and holds a majority stake in the lung cancer screening software market as key market players expand their product portfolio and will contribute to the ongoing strategic partnership responsible for the majority of shares held in the region.

The country section of the report also provides individual lung cancer screening software market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North American brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Lung Cancer Screening Software Market 

Lung cancer screening software market also provides you with detailed market analysis for every country growth in aesthetic industry with lung cancer screening software sales, impact of advancement in the lung cancer screening software and changes in regulatory scenarios with their support for the lung cancer screening software market. The data is available for historic period 2010 to 2018.  

Competitive Landscape and Lung Cancer Screening Software Market Share Analysis

Lung cancer screening software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to lung cancer screening software market.

The major players covered in the North America lung cancer screening software market report are Medtronic, PenRad Technologies Inc., Koninklijke Philips N.V., Volpara Solutions Limited, Lungview, Siemens Healthcare Private Limited, Thynk Health, Eon, Nuance Communications, Inc., MeVis Medical Solutions AG, Vital Images (a subsidiary of Canon Group Company), HealthMyne, Optellum Ltd, MyCareWare Inc, ProVation Medical, Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ which are also accelerating the lung cancer screening software market.

For instance,

  • In May 2020, Koninklijke Philips N.V. has been listed into “Worlds’ Largest Public Company” and earned a place on the Forbes “Global 2000, moving up 46 spots from 2019. In its new position, the company now also ranks as one of the top ten global public healthcare companies. This will help the company to uplift the brand image in the market and will also help to gain trust of customers.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the lung cancer screening software market which also provides the benefit for organisation to improve their offering for lung cancer screening software.  

Customization Available: North America Lung Cancer Screening Software Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2018-2027 (USD THOUSAND)

TABLE 2 NORTH AMERICA CLOUD BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 3 NORTH AMERICA ON-PREMISE SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 4 NORTH AMERICA WEB BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 5 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 6 NORTH AMERICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 7 NORTH AMERICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 8 NORTH AMERICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 9 NORTH AMERICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 10 NORTH AMERICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 11 NORTH AMERICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 12 NORTH AMERICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 13 NORTH AMERICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 14 NORTH AMERICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 15 NORTH AMERICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 16 NORTH AMERICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 17 NORTH AMERICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 18 NORTH AMERICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 19 NORTH AMERICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 20 NORTH AMERICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 21 NORTH AMERICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 22 NORTH AMERICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 23 NORTH AMERICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 24 NORTH AMERICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 25 NORTH AMERICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 26 NORTH AMERICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 27 NORTH AMERICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND)

TABLE 28 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 29 NORTH AMERICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 30 NORTH AMERICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 31 NORTH AMERICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 32 NORTH AMERICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 33 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 34 NORTH AMERICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 35 NORTH AMERICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2018-2027 (USD THOUSAND)

TABLE 36 NORTH AMERICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 37 NORTH AMERICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)

TABLE 38 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND)

TABLE 39 NORTH AMERICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 40 NORTH AMERICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND)

TABLE 41 NORTH AMERICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 42 NORTH AMERICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND)

TABLE 43 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2018-2027 (USD THOUSAND)

TABLE 44 NORTH AMERICA INSTITUTIONAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 45 NORTH AMERICA INDIVIDUAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 46 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2018-2027 (USD THOUSAND)

TABLE 47 NORTH AMERICA ONCOLOGY CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 48 NORTH AMERICA HOSPITALS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 49 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 50 NORTH AMERICA OTHERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 51 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 52 NORTH AMERICA DIRECT TENDERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 53 NORTH AMERICA THIRD PARTY DISTRIBUTOR IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2018-2027 (USD THOUSAND )

TABLE 54 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY COUNTRY, 2018–2027 (USD THOUSAND)

TABLE 55 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2018-2027 (USD THOUSAND )

TABLE 56 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 57 NORTH AMERICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 58 NORTH AMERICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 59 NORTH AMERICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 60 NORTH AMERICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 61 NORTH AMERICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 62 NORTH AMERICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 63 NORTH AMERICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 64 NORTH AMERICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 65 NORTH AMERICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 66 NORTH AMERICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 67 NORTH AMERICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 68 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 69 NORTH AMERICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 70 NORTH AMERICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 71 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 72 NORTH AMERICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 73 NORTH AMERICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 74 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 75 NORTH AMERICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 76 NORTH AMERICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 77 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2018-2027 (USD THOUSAND )

TABLE 78 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2018-2027 (USD THOUSAND )

TABLE 79 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND )

TABLE 80 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2018-2027 (USD THOUSAND )

TABLE 81 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 82 U.S. LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 83 U.S. LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 84 U.S. NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 85 U.S. DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 86 U.S. PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 87 U.S. LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 88 U.S. PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 89 U.S. STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 90 U.S. SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 91 U.S. PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 92 U.S. AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 93 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 94 U.S. COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 95 U.S. TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 96 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 97 U.S. NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 98 U.S. SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 99 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 100 U.S. STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 101 U.S. INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 102 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2018-2027 (USD THOUSAND )

TABLE 103 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2018-2027 (USD THOUSAND )

TABLE 104 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND )

TABLE 105 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2018-2027 (USD THOUSAND )

TABLE 106 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 107 CANADA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 108 CANADA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 109 CANADA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 110 CANADA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 111 CANADA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 112 CANADA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 113 CANADA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 114 CANADA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 115 CANADA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 116 CANADA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 117 CANADA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 118 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 119 CANADA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 120 CANADA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 121 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 122 CANADA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 123 CANADA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 124 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 125 CANADA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 126 CANADA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 127 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2018-2027 (USD THOUSAND )

TABLE 128 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2018-2027 (USD THOUSAND )

TABLE 129 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND )

TABLE 130 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2018-2027 (USD THOUSAND )

TABLE 131 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 132 MEXICO LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 133 MEXICO LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 134 MEXICO NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 135 MEXICO DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 136 MEXICO PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 137 MEXICO LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 138 MEXICO PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 139 MEXICO STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 140 MEXICO SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 141 MEXICO PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 142 MEXICO AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2018-2027 (USD THOUSAND )

TABLE 143 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 144 MEXICO COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 145 MEXICO TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2018-2027 (USD THOUSAND )

TABLE 146 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 147 MEXICO NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 148 MEXICO SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND )

TABLE 149 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 150 MEXICO STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 151 MEXICO INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2018-2027 (USD THOUSAND )

TABLE 152 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2018-2027 (USD THOUSAND )

TABLE 153 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2018-2027 (USD THOUSAND )

TABLE 154 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND )

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions